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Introduction
Tufted angioma (TA), also known as 
angioblastoma/angioblastoma of Nakagawa, is a rare 
benign vascular tumor frequently developing in infancy 
and early childhood. The condition is very slowly 
progressive or stationary and occasionally self-remitting. 
During the whole course of TA, the lesion remains 
asymptomatic, the overlying epidermis remains intact and 
the prognosis is favorable [1]. Because of its considerable 
clinical, pathological, and immunohistochemical overlap 
with kaposiform hemangioendothelioma (KHE), both 
tumors are considered to be a spectrum of the same 
disease [2]. The concept of TA/KHE spectrum and 
therefore of a single entity is also adopted by the authors 
of this rarely destructive TA/KHE entity.
Case Report
A 12-year-old male developed several small 
multiple red lesions on the left inner canthus and lower 
eyelid that started 12 months before presentation 
and were gradually and slowly increasing in size and 
number. There were no history of trauma, previous facial 
or eye surgery, or similar lesion elsewhere on the body. 
The patient received topical combination of antibiotics 
and steroids for several weeks without improvement. 
The condition remained asymptomatic and the child 
was otherwise healthy. Examination revealed multiple 
red papules and small non-compressible nodules 
that partially eroded the left lower eyelid margin and 
compromised the closure of the eye so that the medial 
canthus (commissure), lacrimal caruncle, eroded 
inferior lacrimal punctum, and sclera were clearly visible 
even with tight closure of the eyelid (Figure 1). There 
was no affection of the visual acuity and regional lymph 
nodes were not palpable. Likewise, general examination 
revealed no abnormality and complete blood count 
was within normal range. Histopathology revealed 
cannonball pattern in the form of small circumscribed 
angiomatous tufts and lobules scattered in the dermis; 
hence, the diagnosis of TA or TA/KHE was made (Figure 
2a and b). Due to the evident eyelid tissue erosion and 
destruction, surgical excision under general anesthesia 
was performed and no evidence of recurrence was 
observed during a 1-year follow-up period.
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Comment
TA/KHE can be either congenital or acquired 
of unknown etiology, though trauma, high hormonal 
levels during pregnancy or puberty, as in the present 
case, and underlying vascular malformation such as 
port-wine stains has infrequently been reported. The 
tumor appears as ill defined, dull red macules with a 
mottled appearance varying from 1 to 10 cm in size. 
Some show clusters of smaller angiomatous papules 
superimposed on the main macular areas or as an 
exophytic, firm, red or violaceous, cutaneous solitary or 
multiple papules, and nodules as in the present case. 
The lesion progresses slowly over months to years and 
the size of the lesion can be variable, though rarely it 
may undergo spontaneous regression [1], [2].
Figure 2: Histopathologic features showing (a) the characteristic 
vascular tufts “cannonball” dispersed in the superficial and deep 
dermis. (H&E, original magnification ×100). (b) Multiple and narrow 
capillary spaces particularly at the periphery of the tufts in a 
glomeruloid arrangement (H&E, original magnification ×400)
a b
Congenital TA/KHE should be expected 
when a poorly defined congenital infiltrating vascular 
tumor with(out) overlying hirsutism appears over the 
mandibular area, where about three-fourth of all facial 
congenital TA/KHE develop [3].
Although very few cases involving the 
eyelids were reported, none was associated with 
tissue destruction, ulceration, or erosion [4], [5]. The 
pathogenesis of the destruction of the eyelid margin in 
the present case is not known, though it may be due 
to a compromised blood supply by the newly formed 
blood vessels and the nature of vasculature of the 
eyelid margin rather than tumor related as it has been 
observed only in eyelid margin lesions. Other serious 
complication includes Kasabach–Merritt phenomenon 
(KMP) which may develop in about 10% of congenital 
cases of TA and up to 70% in KHE and is manifested 
by widespread ecchymoses and petechiae. KPM is 
characterized by a severe thrombocytopenia with mild 
to moderate coagulopathy resulting from intralesional 
platelet trapping. Occasionally, it may be associated with 
tenderness, hyperhidrosis, and hypertrichosis [1], [6].
No specific laboratory examinations are 
required for the diagnosis or treatment of TA/KHE. 
Complete blood cell count and full disseminated 
intravascular coagulation profile are indicated in the 
presence of manifestations suggestive of KMP [7]. TA 
has a specific histologic pattern in the form of lobular 
arrangement of densely cellular capillaries “cannonball 
pattern” throughout the dermis. The vascular tufts 
consist of tightly packed hypertrophic endothelial cells 
with scanty cytoplasm and nuclei that are round, ovoid, 
or fusiform. Mitoses are infrequent and hemosiderin 
deposits may be observed within the endothelial cells. 
Capillary spaces are narrow and elongated, and more 
noticeable in the periphery of the lobules, where they 
have a characteristic half-moon shape. These findings 
were evident in the present case, hence favoring the TA 
of the spectrum (Figure 2a and b) [2], [7], [8].
Positive staining for vascular markers CD 
31, CD 34, alpha-smooth muscle actin (rare), and the 
lymphatic marker D2-40 and PROX1 and negative 
staining of GLUT-1 denote both the existence of two 
cellular components in TA/KHE and the immaturity of 
endothelial cells [8]. Immunohistochemistry is confusing 
and inconclusive in differentiating TA from the more 
locally aggressive KHE and, in practice, it is usually 
deferred as in this case [2].
Differential diagnosis of the TA/KHE 
includes pyogenic granuloma, benign neoplasms of 
endothelial origin, and Kaposi sarcoma. However, the 
histopathological and immunohistochemical findings 
are specific and these lesions exhibit individual 
characteristics by which they can be distinguished from 
TA/KHE [2], [9].
The prognosis is favorable; hence, 
observation is the best course of action. Cryosurgery, 
radiation therapy, electrocoagulation, and pulsed dye 
laser are successful to varying degrees, whereas local 
injection of interferon-alpha is a non-surgical option 
in growing lesions [10]. For patients who develop 
KMP, the first-line therapy consists of vincristine 
plus prednisone or sirolimus (rapamycin). Aspirin 
may also help to control the platelet interaction, 
pain, and growth of TA/KHE [11], [12]. Topical timolol 
maleate is an option for limited lesions [13]. Surgical 
excision allows permanent removal of the TA and 
Figure 1: Multiple erythematous papules and nodules in the left 
canthus and lower eyelid with partial erosion of its margin resulting 
in incomplete closure of the left eye with destruction of the medial 
margin and inferior lacrimal punctum and exposure of the underlying 
lacrimal caruncle and sclera
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was preferred in the present case to preserve the 
function and structure of the partially damaged eyelid 
and hence the eye.
Conclusion
TA/KHE is a rare vascular benign neoplasm 
usually asymptomatic but may affect delicate structures, 
such as the eyelid resulting in destruction and hence 
may require rapid surgical intervention.
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